Invus Advisors, L.L.C. is Director & 10% Owner at LEXICON PHARMACEUTICALS, INC./DE (LXRX). They have made 6 open-market trades across 2 companies since 2008, most recently 2017-11-17.
CIK 0001404553
4 open-market purchases totalling $27.7M since 2008, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LXRX | BUY | 2017-11-15 | 2017-11-17 | $10.15 | $3.2M | +4.5% | +3.5% | -18.9% |
| BUFF | SELL | 2016-07-05 | 2016-07-07 | $21.29 | $639.3M | -1.0% | +0.4% | +0.4% |
| BUFF | SELL | 2015-07-27 | 2015-07-27 | $20.00 | $569.3M | -1.0% | +0.4% | +0.4% |
| LXRX | BUY | 2009-10-14 | 2009-10-15 | $1.50 | $23.2M | -21.0% | +0.6% | +0.6% |
| LXRX | BUY | 2008-08-23 | 2007-08-24 | $— | — | -21.0% | +0.6% | +0.6% |
| LXRX | BUY | 2008-04-30 | 2008-05-02 | $2.00 | $1.3M | -21.0% | +0.6% | +0.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.